Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.12 AUD | +1.36% | +13.13% | +261.29% |
07-02 | Mesoblast to File Biological License Application with US FDA for Cellular Therapy | MT |
07-01 | Mesoblast to File Biologics License Application for Ryoncil | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+261.29% | 851M | |
+18.10% | 45.34B | |
+41.98% | 40.42B | |
-9.97% | 37.92B | |
+32.10% | 31.75B | |
-8.98% | 27.71B | |
+12.90% | 26.52B | |
+44.71% | 13.96B | |
+31.96% | 12.44B | |
-6.22% | 11.26B |
- Stock Market
- Equities
- MSB Stock
- News Mesoblast Limited
- Maxim Downgrades Mesoblast to Hold From Buy